| RNAZ Stock | | | USD 0.67 0.06 9.84% |
Transcode Therapeutics financial indicator trend analysis is much more than just breaking down Transcode Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Transcode Therapeutics is a good investment. Please check the relationship between Transcode Therapeutics Other Liab and its Long Term Debt accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For more information on how to buy Transcode Stock please use our
How to Invest in Transcode Therapeutics guide.
Other Liab vs Long Term Debt
Other Liab vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Transcode Therapeutics Other Liab account and
Long Term Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Transcode Therapeutics' Other Liab and Long Term Debt is 0.95. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Transcode Therapeutics, assuming nothing else is changed. The correlation between historical values of Transcode Therapeutics' Other Liab and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Transcode Therapeutics are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Other Liab i.e., Transcode Therapeutics' Other Liab and Long Term Debt go up and down completely randomly.
Correlation Coefficient | 0.95 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Other Liab
Long Term Debt
Long-term debt is a debt that Transcode Therapeutics has held for over one year. Long-term debt appears on Transcode Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Transcode Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Transcode Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Transcode Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For more information on how to buy Transcode Stock please use our
How to Invest in Transcode Therapeutics guide.At this time, Transcode Therapeutics'
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 0.06 in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.3
M in 2024.
Transcode Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Transcode Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Transcode Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Transcode Stock Analysis
When running Transcode Therapeutics' price analysis, check to
measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.